The U.S. Food and Drug Administration (FDA) has granted fast-track designation to pevifoscorvir sodium, Aligos Therapeutics‘ oral therapy candidate for chronic hepatitis B, which…

Long-term, off-label treatment with fenofibrate significantly reduces liver damage markers and improves prognostic scores in primary biliary cholangitis (PBC) patients who do not respond…

A genetic susceptibility to gestational diabetes mellitus (GDM), a common pregnancy complication marked by intolerance to blood sugar due to low levels of the insulin…